comparemela.com
Home
Live Updates
Neoadjuvant Pembrolizumab Shows Promise for Cisplatin-Ineligible MIBC : comparemela.com
Neoadjuvant Pembrolizumab Shows Promise for Cisplatin-Ineligible MIBC
Investigators studied neoadjuvant pembrolizumab in patients with bladder cancer (MIBC) having cystectomy who were ineligible for cisplatin.
Related Keywords
Florida ,
United States ,
California ,
Tampa ,
San Francisco ,
American ,
Kylem Rose ,
,
American Society Of Clinical Oncology ,
H Lee Moffitt Cancer Center ,
American Society ,
Clinical Oncology ,
Cancers Symposium ,
Moffitt Cancer Center ,
comparemela.com © 2020. All Rights Reserved.